Lee Soo Hee, Park Kyeong-Eon, Kwon Seong-Chun, Ok Seong-Ho, Ahn Seung Hyun, Sim Gyujin, Sohn Ju-Tae
Department of Anesthesiology and Pain Medicine, Gyeongsang National University Changwon Hospital, Changwon-si 51472, Gyeongsangnam-do, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Gyeongsang National University College of Medicine, Jinju-si 52727, Gyeongsangnam-do, Republic of Korea.
Int J Mol Sci. 2025 May 9;26(10):4556. doi: 10.3390/ijms26104556.
Although chloroquine appears to inhibit the alpha-1 adrenoceptor, whether the chloroquine-mediated inhibition of phenylephrine-induced contraction is associated with the blockade of alpha-1 adrenoceptors remains unknown. This study examined the effect of chloroquine on contractions elicited by the alpha-1 adrenoceptor agonist phenylephrine in isolated rat aortas and determined the underlying mechanism. The effects of chloroquine and the alpha-1 adrenoceptor inhibitor prazosin on phenylephrine-elicited contractions were examined. The effects of the irreversible alpha-adrenoceptor inhibitor phenoxybenzamine followed by washout with fresh Krebs solution, as well as combined treatment with chloroquine and phenoxybenzamine followed by washout with fresh Krebs solution, on phenylephrine-induced contraction were investigated. Chloroquine and prazosin inhibited phenylephrine-induced contractions. However, pretreatment with prazosin eliminated the chloroquine-induced inhibition of contractions elicited by phenylephrine. Additionally, pretreatment with chloroquine and phenoxybenzamine followed by washout produced a higher contraction elicited by phenylephrine than pretreatment with phenoxybenzamine alone followed by washout. Although chloroquine did not affect the contraction induced by KCl in the endothelium-denuded aorta, it inhibited phenylephrine-induced protein kinase C (PKC) and myosin light-chain (MLC) phosphorylation and Rho-kinase membrane translocation. These results suggest that chloroquine inhibits vasoconstriction elicited by phenylephrine via alpha-1 adrenoceptor inhibition, which is mediated by decreased MLC phosphorylation, the attenuation of PKC phosphorylation, and Rho-kinase membrane translocation.
尽管氯喹似乎能抑制α-1肾上腺素能受体,但氯喹介导的对去氧肾上腺素诱导的收缩的抑制作用是否与α-1肾上腺素能受体的阻断有关仍不清楚。本研究检测了氯喹对离体大鼠主动脉中α-1肾上腺素能受体激动剂去氧肾上腺素引起的收缩的影响,并确定了其潜在机制。检测了氯喹和α-1肾上腺素能受体抑制剂哌唑嗪对去氧肾上腺素引起的收缩的影响。研究了不可逆α-肾上腺素能受体抑制剂酚苄明先用新鲜Krebs溶液冲洗,以及氯喹和酚苄明联合处理后用新鲜Krebs溶液冲洗对去氧肾上腺素诱导的收缩的影响。氯喹和哌唑嗪抑制去氧肾上腺素引起的收缩。然而,先用哌唑嗪预处理可消除氯喹对去氧肾上腺素引起的收缩的抑制作用。此外,先用氯喹和酚苄明预处理后冲洗,去氧肾上腺素引起的收缩比单独用酚苄明预处理后冲洗更高。尽管氯喹不影响内皮剥脱主动脉中氯化钾诱导的收缩,但它抑制去氧肾上腺素诱导的蛋白激酶C(PKC)和肌球蛋白轻链(MLC)磷酸化以及Rho激酶膜转位。这些结果表明,氯喹通过抑制α-1肾上腺素能受体来抑制去氧肾上腺素引起的血管收缩,这是由MLC磷酸化降低、PKC磷酸化减弱和Rho激酶膜转位介导的。